China NMPA Product Recall - Mycobacterium tuberculosis complex and drug resistance gene mutation detection kit (PCR-linear hybridization enzyme colorimetric method)
China NMPA product recall for Mycobacterium tuberculosis complex and drug resistance gene mutation detection kit (PCR-linear hybridization enzyme colorimetric method) by Roche Diagnostics Products (Shanghai) Co., Ltd. published December 30, 2021. Recall level: Level 3 Recall. BioMérieux Diagnostics (Shanghai) Co., Ltd. initiated a Class III voluntary recall for its Mycobacte
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Mycobacterium tuberculosis complex and drug resistance gene mutation detection kit (PCR-linear hybridization enzyme colorimetric method) by Roche Diagnostics Products (Shanghai) Co., Ltd. published December 30, 2021. Recall level: Level 3 Recall. BioMérieux Diagnostics (Shanghai) Co., Ltd. initiated a Class III voluntary recall for its Mycobacte
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox